On March 19, President Emmanuel Macron said “the Covid-19 crisis reminds us of the vital nature of scientific research and […]
Blog
Angiosafe – Covid-19
Diabetic patients are known to be at increased risk of infections. This is especially the case for viral infections and […]
Top Tips for Working from Home During the Coronavirus Pandemic
The global spread of COVID-19 is keeping people at home. Much of the world is on lockdown, and even in […]
CoviDIAB
CoviDIAB Personalized support during the coronavirus epidemic For diabetic patients confined during the COVID-19 epidemic, the AP-HP, in partnership with […]
Jean-Pierre Riveline publishes in JCEM
Type 2 diabetes is known to be one of the most complex chronic diseases. Well-defined diabetes risk factors include environmental […]
Louis Potier publishes in Diabetes Care
Lower-extremity amputation (LEA) is a major complication of diabetes and is associated with low quality of life and higher risk […]
NR, Metabolism & Inflammation meeting @ IMMEDIAB
On the 27th of November the IMMEDIAB Lab is organising a themed meeting on Nuclear Receptors, Metabolism and Inflammation, all […]
Frédéric Fumeron publishes in Mol Metab
The present work was done in collaboration with the REGLYS team headed by Christophe Magnan at the Functional and Adaptative […]
We’re Recruiting!
The IMMEDIAB Lab is recruiting a new postdoc, find the deets below!
WCI Sydney 2019
This week the IMMEDIAB Lab attended the 14th World Congres on Inflammation (WCI) at Sydney, Australia. The event ran from the 15th […]
